Cross National Spending on Generics

From last week’s On The Record offerings, The Global Use of Medicines: Outlook Through 2015 from The IMS Institute of Health Care Informatics (slide 11). The figure shows that the percentage of the spending on pharmaceuticals that is comprised by generics differs across several developed nations. From a low of Japan (5% in 2010, projected 8-9% in 2015) to South Korea (31.7% in 2010, projected 34-35% in 2015). In the U.S., the percentage of spending on pharma that is comprised by generics is projected to rise from 13.4% in 2010, to 21-22% by 2015. Update: I clarified that figure shows % of spending and not % of prescriptions. h/t Brad Flansbaum for the close eye.

 

About Don Taylor
Professor of Public Policy at Duke University (with appointments in Business, Nursing, Community and Family Medicine, and the Duke Clinical Research Institute). I am one of the founding faculty of the Margolis Center for Health Policy, and currently serve as Chair of Duke's University Priorities Committee (UPC). My research focuses on improving care for persons who are dying, and I am co-PI of a CMMI award in Community Based Palliative Care. I teach both undergrads and grad students at Duke. On twitter @donaldhtaylorjr

One Response to Cross National Spending on Generics

  1. steve says:

    I thought it also interesting that 78% of all prescriptions are for generics, page 22, and that when a medicine goes generic within 6 months, the generics capture 80% of that market. Within a year, it is almost 100%.

    Steve

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: